Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
XOMA Royalty Corp | SVP, Finance & CFO | Performance Stock Units | 73.8K | $2.21M | $29.94 | Nov 11, 2024 | Direct |
XOMA Royalty Corp | SVP, Finance & CFO | Common Stock | 14.6K | $436K | $29.94 | Nov 13, 2024 | Direct |
XOMA Royalty Corp | SVP, Finance & CFO | Common Stock | 5.55K | $166K | $29.94 | Nov 11, 2024 | By 401(k) Plan |
Acorda Therapeutics, Inc. | Director | Non-Employee Stock Option | 2.4K | Jun 22, 2023 | Direct | ||
XOMA Royalty Corp | SVP, Finance & CFO | 8.625% Series A Cumulative Perpetual Preferred Stock | 2K | Nov 11, 2024 | Direct | ||
XOMA Royalty Corp | SVP, Finance & CFO | Depository Shares - 8.375% Series B Perpetual Preferred | 1K | Nov 11, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
XOMA | XOMA Royalty Corp | Nov 11, 2024 | 3 | -$293K | 4 | Nov 13, 2024 | SVP, Finance & CFO |
ACOR | Acorda Therapeutics, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
ACOR | Acorda Therapeutics, Inc. | Jun 22, 2023 | 0 | $0 | 3 | Jun 23, 2023 | Director |
XOMA | XOMA Corp | May 18, 2023 | 1 | $0 | 4 | May 22, 2023 | SVP, Finance & CFO |
XOMA | XOMA Corp | Nov 8, 2022 | 1 | $0 | 4 | Nov 9, 2022 | SVP, Finance & CFO |
XOMA | XOMA Corp | Jul 15, 2022 | 3 | -$55.3K | 4 | Jul 18, 2022 | SVP, Finance & CFO |
XOMA | XOMA Corp | Mar 21, 2022 | 9 | -$365K | 4 | Mar 23, 2022 | SVP, Finance & CFO |
XOMA | XOMA Corp | Feb 22, 2022 | 1 | $0 | 4 | Feb 23, 2022 | SVP, Finance & CFO |